Literature DB >> 2208532

Nitrous oxide does not exacerbate pulmonary hypertension or ventricular dysfunction in patients with mitral valvular disease.

S N Konstadt1, D L Reich, D M Thys.   

Abstract

Using the rapid-response thermistor pulmonary artery catheter and transoesophageal echocardiography, this study examined the effects of 100 per cent oxygen, 70 per cent nitrous oxide/30 per cent oxygen, and 70 per cent nitrogen/30 per cent oxygen on the pulmonary circulation and ventricular function in ten patients with pulmonary hypertension. In comparison with baseline measurements, nitrous oxide administration resulted in small but statistically significant (P less than 0.05) changes in mean arterial pressure (76 +/- 14 to 67 +/- 12), mean pulmonary arterial pressure (37 +/- 14 to 33 +/- 13 mmHg), and cardiac output (3.7 +/- 1.4 to 3.2 +/- 1.1 L.min-1). Seventy per cent nitrogen resulted in no significant changes from baseline. The repeat 100 per cent oxygen measurements were nearly identical to the nitrous oxide measurements. It is concluded that nitrous oxide does not exacerbate pulmonary hypertension or ventricular dysfunction during high-dose fentanyl anaesthesia in patients with mitral valvular disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208532     DOI: 10.1007/BF03006477

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  11 in total

1.  Increased norepinephrine release from dog pulmonary artery caused by nitrous oxide.

Authors:  D K Rorie; G M Tyce; J C Sill
Journal:  Anesth Analg       Date:  1986-06       Impact factor: 5.108

2.  Bedside evaluation of right ventricular performance using a rapid computerized thermodilution method.

Authors:  J F Dhainaut; F Brunet; J F Monsallier; D Villemant; J Y Devaux; M Konno; J M De Gournay; A Armaganidis; G Iotti; M F Huyghebaert
Journal:  Crit Care Med       Date:  1987-02       Impact factor: 7.598

3.  The cardiovascular effects of morphine sulfate with oxygen and with nitrous oxide in man.

Authors:  K C Wong; W E Martin; T F Hornbein; F G Freund; J Everett
Journal:  Anesthesiology       Date:  1973-06       Impact factor: 7.892

4.  Awareness and recall with high-dose fentanyl-oxygen anesthesia.

Authors:  N Mummaneni; T L Rao; A Montoya
Journal:  Anesth Analg       Date:  1980-12       Impact factor: 5.108

5.  Pulmonary and systemic hemodynamic effects of nitrous oxide in infants with normal and elevated pulmonary vascular resistance.

Authors:  P R Hickey; D D Hansen; M Strafford; J E Thompson; R E Jonas; J E Mayer
Journal:  Anesthesiology       Date:  1986-10       Impact factor: 7.892

6.  The safety and efficacy of esmolol during myocardial revascularization.

Authors:  D Girard; B J Shulman; D M Thys; B P Mindich; S K Mikula; J A Kaplan
Journal:  Anesthesiology       Date:  1986-08       Impact factor: 7.892

7.  Hemodynamic changes during fentanyl--oxygen anesthesia for aortocoronary bypass operation.

Authors:  J L Waller; C C Hug; D M Nagle; J M Craver
Journal:  Anesthesiology       Date:  1981-09       Impact factor: 7.892

8.  Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance.

Authors:  U Schulte-Sasse; W Hess; J Tarnow
Journal:  Anesthesiology       Date:  1982-07       Impact factor: 7.892

9.  Fentanyl-oxygen versus fentanyl-N2O/oxygen anaesthesia in children undergoing cardiac surgery.

Authors:  P Crean; G Koren; G Goresky; J Klein; S Macleod
Journal:  Can Anaesth Soc J       Date:  1986-01

10.  Nitrous oxide for blood pressure control after coronary artery surgery: a dose-response hemodynamic study in postoperative patients.

Authors:  V J DiSesa; J B Mark; J P Gold; F Kidwell; R J Shemin; J J Collins; L H Cohn
Journal:  Ann Thorac Surg       Date:  1987-08       Impact factor: 4.330

View more
  1 in total

1.  Nitrous oxide 1844-1990.

Authors:  J P O'Connor
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.